Alnylam to webcast presentation at 43rd nasdaq virtual investor conference

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that management will present a company overview at the 43rd nasdaq virtual investor conference on friday, december 4, 2020 at 11:00 am et. a live audio webcast of the presentation will be available on the investors section of the company's website at www.alnylam.com/events. a replay will be available on the alnylam website within 48 hours after each event. abou
ALNY Ratings Summary
ALNY Quant Ranking